Hel Pharma Limited in London, W11 4NR

Description

Data updated on: 01-11-2023

Hel Pharma came into being in 2012 as a company enlisted under no 08016198, located at W11 4NR London at 19 Crossways. The company has been in business for 12 years and its status at the time is active. The company's SIC code is 70229 which stands for Management consultancy activities other than financial management. 2022-04-30 is the last time when company accounts were filed.

Right now, the following firm is controlled by 1 managing director: Helen Y., who was arranged to perform management duties on 2012-04-02. Since March 2020 Senay T., had been fulfilling assigned duties for this firm up until the resignation 3 years ago.

Helen Y. is the individual who has control over this firm, owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-04-30	2015-04-30	2016-04-30	2017-04-30	2018-04-30	2019-04-30	2020-04-30	2021-04-30	2022-04-30	2023-04-30
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	632	952	849

Balance Sheet
Cash Bank On Hand			3 354	97 445	913	93 499	44 520
Current Assets	7 762	6 782	7 804	97 445		93 499	45 945	92 691	40 780	21 886
Debtors	1 211	2 333	4 450				1 425
Net Assets Liabilities			849	3 571	913	916	8 096	8 404	9 759	18 027
Cash Bank In Hand	6 551	4 449	3 354
Net Assets Liabilities Including Pension Asset Liability	632	952	849

Capital & Reserves
Called Up Share Capital	100	100	100
Profit Loss Account Reserve	532	852	217
Shareholder Funds	632	952	849

Other Financial Data
Version Production Software							2 020
Accrued Liabilities Not Expressed Within Creditors Subtotal							235	960	720	13
Average Number Employees During Period							1	1	1	1
Creditors			6 955	93 874		92 583	43 939	89 115	30 301	3 846
Net Current Assets Liabilities	632	952	849	3 571	913	916	2 006	9 364	10 479	18 040
Nominal Value Allotted Share Capital			100	100	100	100	100
Number Shares Allotted	100	100	100	100	100	100	100
Other Creditors						91 557	42 275
Par Value Share	1	1	1	1	1	1	1
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal							1 425	5 788
Taxation Social Security Payable			6 955	4 430		1 026	1 429
Total Assets Less Current Liabilities	632	6 782					8 331	9 364	10 479	18 040
Trade Creditors Trade Payables				89 444			235
Trade Debtors Trade Receivables			4 450				1 425
Administrative Expenses	20 380	15 568
Cost Sales		3 200
Creditors Due Within One Year	7 130	5 830	6 955
Gross Profit Loss	56 028	44 718
Operating Profit Loss	35 648	29 150
Profit Loss For Period	28 518	23 320
Profit Loss On Ordinary Activities Before Tax	35 648	29 150
Provisions For Liabilities Charges		5 830
Share Capital Allotted Called Up Paid	100	100	100
Share Premium Account		532	532
Tax On Profit Or Loss On Ordinary Activities	7 130	5 830
Total Dividend Payment	28 000	23 000
Turnover Gross Operating Revenue	56 028	47 918

Company staff

Helen Y.

Role: Secretary

Appointed: 02 April 2012

Latest update: 21 April 2024

Helen Y.

Role: Director

Appointed: 02 April 2012

Latest update: 21 April 2024

People with significant control

Helen Y.

Notified on 6 April 2016

Nature of control:

1/2 or less of shares

Senay T.

Notified on 9 March 2020

Ceased on 8 December 2021

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 January 2024
Account last made up date	30 April 2022
Confirmation statement next due date	05 April 2024
Confirmation statement last made up date	22 March 2023

Annual Accounts 07 December 2015
Start Date For Period Covered By Report	2014-05-01
End Date For Period Covered By Report	2015-04-30
Date Approval Accounts	07 December 2015
Annual Accounts
Start Date For Period Covered By Report	1 May 2016
End Date For Period Covered By Report	30 April 2017
Annual Accounts
Start Date For Period Covered By Report	1 May 2017
End Date For Period Covered By Report	30 April 2018
Annual Accounts
Start Date For Period Covered By Report	1 May 2018
End Date For Period Covered By Report	30 April 2019
Annual Accounts
Start Date For Period Covered By Report	1 May 2019
End Date For Period Covered By Report	30 April 2020
Annual Accounts
Start Date For Period Covered By Report	2020-05-01
End Date For Period Covered By Report	30 April 2021
Annual Accounts
Start Date For Period Covered By Report	2021-05-01
End Date For Period Covered By Report	30 April 2022
Annual Accounts
Start Date For Period Covered By Report	2022-05-01
End Date For Period Covered By Report	30 April 2023
Annual Accounts 23 December 2016
End Date For Period Covered By Report	30 April 2016
Date Approval Accounts	23 December 2016

Hel Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Helen Y.

Helen Y.

Senay T.

People with significant control

Helen Y.

Senay T.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies